A Novel Clinical Nomogram to Predict Transient Symptomatic Associated with Infarction: The ABCD3-SLOPE Score
Table 1
Demographic and clinical characteristics of the patients.
Variables
TIA ()
TSI ()
value
Demographic characteristics
Gender (male, %)
70 (51.9)
66 (69.5)
0.007
Age (years)
65 (59.73)
64 (58.71)
0.516
Clinical data
Duration of TIA (min)
10 (3.60)
30 (9.60)
0.011
Frequency in 24 h (%) 1
112 (83.6)
70 (73.7)
0.097
≥2
22 (16.4)
25 (26.3)
SBPa (mmHg)
0.001
DBPa (mmHg)
0.026
Clinical symptoms
Unilateral weakness (%)
68 (50.4)
69 (72.6)
0.001
Numbness or tingling (%)
41 (30.4)
33 (34.7)
0.579
Speech impairment (%)
29 (21.5)
37 (38.9)
0.006
Diplopia (%)
2 (1.5)
0 (0)
0.513
Dizzy (%)
43 (31.9)
22 (23.2)
0.196
Unconsciousness (%)
9 (6.7)
4 (4.2)
0.566
Bilateral amaurosis, hemianopia (%)
11 (8.1)
4 (4.2)
0.286
Memory loss (%)
20 (14.8)
5 (5.3)
0.030
Facial paralysis (%)
7 (5.2)
12 (12.6)
0.053
Torpor (%)
6 (4.4)
4 (4.2)
1.000
Unilateral amaurosis (%)
5 (3.7)
0 (0)
0.079
Weakness of upper limbs (%)
10 (7.4)
3 (3.2)
0.248
PMH
Hypertension (%)
91 (67.4)
64 (67.4)
1.000
Diabetes mellitus (%)
32 (23.7)
26 (27.4)
0.634
Atrial fibrillation (%)
4 (3.0)
12 (12.6)
0.007
Hyperlipidemia (%)
27 (20.0)
19 (20.0)
1.000
Stroke (%)
21 (15.6)
17 (17.9)
0.772
TIA (%)
48 (35.6)
33 (34.7)
1.000
Dual TIAa (%)
28 (20.7)
28 (29.5)
0.173
Coronary heart disease (%)
10 (7.4)
7 (7.4)
1.000
Tumor (%)
6 (4.4)
5 (5.3)
0.776
Renal insufficiency (%)
8 (5.9)
2 (2.1)
0.202
Smoking (%)
33 (24.4)
46 (48.4)
<0.001
Drinking (%)
19 (14.1)
24 (25.3)
0.049
Drug history
Antiplatelet drugs (%)
18 (13.3)
8 (8.4)
0.344
Statins (%)
10 (7.4)
3 (3.2)
0.278
Anticoagulants (%)
1 (1.1)
1 (0.7)
1.000
ABCD scores
ABCD2
3 (2.4)
4 (3.5)
<0.001
ABCD3
4 (2.5)
5 (4.6)
<0.001
PMH: past medical history; SBPa: the first systolic blood pressure after admission; DBPa: the first diastolic blood pressure after admission; dual TIAa prompting medical attention plus at least one other TIA in the preceding 7 days.
